mylan t/o of agila -> poh

Imho the recent $1.6B Mylan t/o of Agila cannot be underestimated.

POH licensed Agila to use TPM in its injectables. Agila strides injectables unit is such a classy outfit that they completed the most filings and gained the most approvals with FDA compared to their peers due to their cutting edge facilities.

Now to Mylan - it's wanting to expand its injectable empire especially into generics where in the US and elsewhere around the world there is a shortage. Mylan is a major and if we can buddy up with them and improve just a fraction of the many injectables they have on offer. Look out.

Would love to say that a AUS bio from Clayton has bridges to such great companies as Mylan & Novartis....cha-chinga!